To address this question, we measured the relative content of several important neurotransmitters, such as AChE, ACh, dopamine, GABA, glutamate, glycine, and AD-related proteins like amyloid beta 42 (Aβ42) and p-Tau in the brain using ELISA assays. The gene discussed is MAPT; the disease is Alzheimer disease.